Evidence map›Paper›PMID 23210770›Full record

ArticleOrganic letters2012

Substituted imidazo[1,2-a]pyridines as β-strand peptidomimetics.

Chang Won Kang, Yongmao Sun, Juan R Del Valle

Abstract read
In one paragraph

Article in Organic letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Systematic Targeting of Protein-Protein Interactions.Trends in pharmacological sciences · 2016
    Review
  5. Imidazo[1,2-a]pyridine-based peptidomimetics as inhibitors of Akt.Bioorganic & medicinal chemistry letters · 2014
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chang Won KangDrug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, United States.
Yongmao Sun
Juan R Del Valle

Funding

Targeting Akt with substrate mimetic antagonistsR21CA167215 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI DEL VALLE, JUAN R · 2012 to 2013
$392k
NCI NIH HHS CA167215NCI NIH HHS R21 CA167215
6 · The paper itself

Abstract

New conformationally extended dipeptide surrogates based on an imidazo[1,2-a]pyridine scaffold are described. Efficient synthesis and incorporation into host peptides affords structures with native side-chain functionality and hydrogen bonding elements on one face of the backbone. Structural analysis by NMR suggests that model peptidomimetics adopt a β-strand-like conformation in solution.

Indexed as

ImidazolesModels, MolecularMolecular StructurePeptidesPeptidomimeticsProtein Structure, SecondaryPyridinesImidazolesPeptidesPeptidomimeticsPyridines

Identifiers

PMID23210770
PMCPMC3528799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.